MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$3,300,337
(1.16%↑ Y/Y)
Interest income
$126,316
(-60.30%↓ Y/Y)
Loss from operations
-$3,426,653
(6.31%↑ Y/Y)
Total expenses
$3,426,653
(-6.31%↓ Y/Y)
General and
administrative
$1,729,935
(-12.40%↓ Y/Y)
Research and development
$1,696,718
(0.84%↑ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Inhibitor Therapeutics, Inc. (INTI)
Inhibitor Therapeutics, Inc. (INTI)